Sheng‐Chieh Chou

1.0k total citations
27 papers, 253 citations indexed

About

Sheng‐Chieh Chou is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Sheng‐Chieh Chou has authored 27 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Sheng‐Chieh Chou's work include Platelet Disorders and Treatments (5 papers), Hemophilia Treatment and Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Sheng‐Chieh Chou is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Hemophilia Treatment and Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Sheng‐Chieh Chou collaborates with scholars based in Taiwan, United States and Switzerland. Sheng‐Chieh Chou's co-authors include Jar‐Yi Ho, Dah‐Shyong Yü, Chia‐Lun Wu, Hwei‐Fang Tien, Ming Yao, Jih‐Luh Tang, Woei Tsay, Shang‐Yi Huang, Hsin‐An Hou and Shu‐Wha Lin and has published in prestigious journals such as Blood, PLoS ONE and The American Journal of Surgical Pathology.

In The Last Decade

Sheng‐Chieh Chou

25 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng‐Chieh Chou Taiwan 8 132 108 64 57 30 27 253
Andrea Zangrando Italy 8 147 1.1× 123 1.1× 95 1.5× 46 0.8× 25 0.8× 9 303
W.-K. Hofmann Germany 7 159 1.2× 120 1.1× 61 1.0× 34 0.6× 17 0.6× 9 268
Mitsuteru Hiwatari Japan 8 137 1.0× 47 0.4× 49 0.8× 42 0.7× 30 1.0× 23 251
M Soda Japan 5 172 1.3× 139 1.3× 66 1.0× 58 1.0× 25 0.8× 9 312
Mark Mansour Canada 6 63 0.5× 86 0.8× 36 0.6× 57 1.0× 14 0.5× 10 182
Shayu Deshpande United States 9 113 0.9× 117 1.1× 59 0.9× 26 0.5× 48 1.6× 17 215
Xiaoqi Qin China 9 156 1.2× 172 1.6× 118 1.8× 56 1.0× 26 0.9× 27 284
Julia Ellermann Germany 3 119 0.9× 29 0.3× 60 0.9× 70 1.2× 25 0.8× 3 251
Carlos Hader United States 5 67 0.5× 215 2.0× 53 0.8× 51 0.9× 29 1.0× 7 299
Dorothea Douglas United States 5 127 1.0× 35 0.3× 80 1.3× 58 1.0× 15 0.5× 7 239

Countries citing papers authored by Sheng‐Chieh Chou

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Chieh Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Chieh Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Chieh Chou more than expected).

Fields of papers citing papers by Sheng‐Chieh Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Chieh Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Chieh Chou. The network helps show where Sheng‐Chieh Chou may publish in the future.

Co-authorship network of co-authors of Sheng‐Chieh Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Chieh Chou. A scholar is included among the top collaborators of Sheng‐Chieh Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Chieh Chou. Sheng‐Chieh Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chou, Sheng‐Chieh, et al.. (2025). Tissue factor, factor VIII and IX in microvesicle-induced thrombosis and tumor growth of pancreatic cancer. Thrombosis Journal. 23(1). 32–32. 1 indexed citations
2.
Pan, Szu‐Yu, Yi-Chan Lin, Huiting Liu, et al.. (2024). The effects of double-filtration plasmapheresis on coagulation profiles and the risk of bleeding. Journal of the Formosan Medical Association. 123(8). 899–903. 1 indexed citations
3.
Chiou, Shyh‐Shin, Jiaan‐Der Wang, Sheng‐Chieh Chou, et al.. (2024). Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study. Drugs - Real World Outcomes. 11(4). 711–723.
5.
Röth, Alexander, Rong Fu, Guangsheng He, et al.. (2024). Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies. European Journal Of Haematology. 114(2). 373–382. 1 indexed citations
6.
Chou, Sheng‐Chieh, Yung‐Li Yang, Shu‐Huey Chen, et al.. (2024). Recapitulating the immune system of hemophilia A patients with inhibitors using immunodeficient mice. Thrombosis Research. 235. 155–163. 1 indexed citations
7.
Chou, Sheng‐Chieh, et al.. (2023). Gene therapy for hemophilia, a clinical viewpoint. Journal of the Formosan Medical Association. 122(11). 1101–1110. 3 indexed citations
8.
Mahlangu, Johnny, Annette von Drygalski, Susan Shapiro, et al.. (2023). OC 20.1 Bleeding, FVIII Activity, and Safety 3 Years After Gene Transfer with Valoctocogene roxaparvovec: Results from GENEr8-1. Research and Practice in Thrombosis and Haemostasis. 7. 100459–100459. 2 indexed citations
9.
Chou, Sheng‐Chieh, et al.. (2022). Minimally Invasive Neurosurgery for Spontaneous Intracerebral Hemorrhage—10 Years of Working Progress at National Taiwan University Hospital. Frontiers in Neurology. 13. 817386–817386. 7 indexed citations
10.
Chou, Sheng‐Chieh, et al.. (2022). Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation. International Journal of Hematology. 116(4). 528–533. 2 indexed citations
11.
Chou, Sheng‐Chieh, et al.. (2021). Incidence and risk factors for venous thromboembolism in a cohort of Taiwanese patients with lung, gastric, pancreatic cancers or lymphoma. Journal of the Formosan Medical Association. 121(1). 360–366. 9 indexed citations
12.
Kuo, Lu‐Ting, Chih‐Hao Chen, Woon‐Man Kung, et al.. (2021). Surgery for Coagulopathy-Related Intracerebral Hemorrhage: Craniotomy vs. Minimally Invasive Neurosurgery. Life. 11(6). 564–564. 2 indexed citations
13.
Chou, Sheng‐Chieh, et al.. (2020). Acquired FXIII inhibitor: Patient characteristics and treatment outcome, a case series in Taiwan. Journal of the Formosan Medical Association. 120(1). 411–414. 2 indexed citations
14.
Tang, Shuyu, et al.. (2019). Uncommon Presentation of Combined Graves' Disease and Pulmonary Embolism in a 32-year-old Woman. 30(5). 351–357. 1 indexed citations
15.
Fan, Mengni, et al.. (2016). Current animal models of hemophilia: the state of the art. Thrombosis Journal. 14(S1). 22–22. 21 indexed citations
16.
18.
Chou, Sheng‐Chieh, Jih‐Luh Tang, Hsin‐An Hou, et al.. (2014). Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations. Leukemia Research. 38(11). 1278–1284. 16 indexed citations
19.
Chou, Sheng‐Chieh, et al.. (2004). Organ-Preserving Surgery for 2 Epidermoid Cysts in 1 Testis Using Ultrasonography and Magnetic Resonance Imaging. 15(2). 84–88. 1 indexed citations
20.
Chou, Sheng‐Chieh, et al.. (1964). A NUMERICAL EXPERIMENT OF CUMULUS DEVELOPMENT. Acta Meteorologica Sinica. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026